In a retrospective review of records of more than 25,000 pregnant women treated at the Mayo Clinic in Rochester, Minn., from 1993 through 2005, there was no organization within the mothers’ SSRI use during pregnancy and the occurrence of congenital heart disease, ventricular septal defects, or persistent pulmonary hypertension in their

SAN DIEGO, May 23 — In utero exposure to selective serotonin reuptake inhibitors was not significantly associated with the risk for cardiac malformations or persistent pulmonary hypertension. Wichman, D.O., and colleagues at the American Psychiatric organization meeting here. All Rights Reserved.

Original post by Anxiety Insights